Results 191 to 200 of about 88,319 (314)

Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria

Journal of Virology, 2015
M. Famulare, Stewart T. Chang, Jane Iber, Kun Zhao, J. Adeniji, D. Bukbuk, M. Baba, Matthew R Behrend, C. Burns, M. Oberste   +9 more
semanticscholar   +1 more source

Higher stability of novel live-attenuated oral poliovirus type 2 (nOPV2) despite the emergence of a neurovirulent double recombinant strain in Uganda. [PDF]

Nat Microbiol
Tushabe P, Majumdar M, Carlyle S, Shulman L, Ssekagiri A, Joffret ML, Klapsa D, Cremer J, Arowolo KO, Bujaki E, Bukenya H, EPI Laboratory team, Nanteza MB, Turyahabwe I, Namuwulya P, Birungi M, Eliku JP, Aine F, Tibanagwa M, Nakabazzi L, Gaizi J, Ssebuuma AM, Dhatemwa R, Okia C, Nyachwo M, Nanteza MB, Turyahabwe I, Namuwulya P, Birungi M, Eliku JP, Aine F, Tibanagwa M, Nakabazzi L, Gaizi J, Ssebuuma AM, Dhatemwa R, Okia C, Nyachwo M, Hawes KM, Bakamutumaho B, Duizer E, Bessaud M, Bandyopadhyay AS, Macadam A, Byabamazima CR, Martin J, Bwogi J.   +46 more
europepmc   +1 more source

Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.

Journal of Infectious Diseases, 2015
D. A. Kalkowska, R. D. Duintjer Tebbens, I. Grotto, L. Shulman, E. Anis, S. Wassilak, M. Pallansch, K. Thompson   +7 more
semanticscholar   +1 more source

Virucidal efficacy of a UV-C disinfection system for semi-critical medical devices according to EN 14476. [PDF]

GMS Hyg Infect Control
Rudhart SA, Eichhorn KWG, Rausch M, Maas A, Knof M, Engelhart S, Mutters NT, Hoch S, Strieth S.   +8 more
europepmc   +1 more source

An outbreak of circulating vaccine derived poliovirus in Yemen, 2011-2012 [PDF]

, 2014
A.A.T. Jaawal
openalex   +1 more source

Factors associated with the circulation of vaccine-derived polioviruses in children under five in Kilwa, Haut-Katanga province, Democratic Republic of Congo, 2022-2023. [PDF]

BMC Infect Dis
Iyala JBY, Degbey CC, Elumbu G, Tshinkenke BK, Nadakou N, Kieng GK, Tuni BN, Makala JP.   +7 more
europepmc   +1 more source

Estimating population immunity against serotype-two poliomyelitis from the inactivated polio vaccine in routine immunization across 112 countries: A modelling study. [PDF]

PLoS Med
Gray EJ, Cooper LV, Gonzalez AR, Mach O, Derqui N, Grassly NC, Blake IM.   +6 more
europepmc   +1 more source

Nanopore Sequencing of poliovirus isolates v1 [PDF]

Catherine Troman, Erika Bujáki, Joyce Akello, Shannon Fitz, Alex Shaw, Javier Martín, Nick Grassly   +6 more
openalex   +1 more source

Intramuscular versus intradermal administration of fractional dose inactivated poliovirus vaccine in Mozambique, 2020-2022: an, open-label, non-inferiority, randomised, controlled phase 2 trial. [PDF]

EClinicalMedicine
Omar Viegas E, Fumane E, Pereira K, Amade M, Jani I, Guilche O, Cubai C, Valdez S, Mainou BA, Lopez Cavestany R, Jeyaseelan V, Mach O.   +11 more
europepmc   +1 more source

Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial [PDF]

, 2017
Jingjun Qiu, Yunkai Yang, Lirong Huang, Ling Wang, Zhiwei Jiang, Jian Gong, Wei Wang, Hongyan Wang, Shaohong Guo, Chanjuan Li, Shuyuan Wei, Zhaojun Mo, Jielai Xia   +12 more
openalex   +1 more source